Thursday, April 25, 2024
ADVT 
Health

Some coffee with your coffee? Dunkin' launching cereal line

Darpan News Desk The Canadian Press, 11 Aug, 2020 09:56 PM
  • Some coffee with your coffee? Dunkin' launching cereal line

As if 2020 wasn’t weird enough, Dunkin’ is getting into the cereal game.

The Massachusetts-based coffee and donuts empire is releasing two new breakfast cereals based on two of its most popular coffee drinks: Caramel Macchiato and Mocha Latte.

The team-up with Post Consumer Brands, the makers of Honey Bunches of Oats, Shredded Wheat, Raisin Bran and other familiar cereals, is expected to hit grocery shelves later this month.

The companies say Dunkin' coffee concentrate is added to the cereal, which consists of little crunchy spheres mixed with flavoured marshmallow bits. A serving has about as much caffeine as a tenth of an 8-ounce cup of coffee.

Reaction on social media has ranged from enthusiastic anticipation to horrified yet intrigued. Skeptics -- and there are many -- see another sign of the apocalypse while others see redemption for an otherwise dreadful year. “I love to pretend like I’m not a die hard New Englander but if I don’t get to try the Dunkin’ donut cereal, I will absolutely lose my mind,” said one Twitter user. Still others see a marketing opportunity missed.

A 10-year-old girl who recently taste-tested the cereals for The Boston Globe suggested: “They should make a doughnut flavoured cereal.” To be sure, the doughnut chain did try just that.

It launched a cereal line based on their popular glazed and chocolate donuts in the 1980s that didn’t exactly take off. But the company’s interest in trying to break into the market again is understandable: nearly 65% of American adults drink coffee every day and nearly 90% of U.S. households consume cereal, according to Dunkin’.

The cereal effort comes as Dunkin’s brick-and-mortar shops, like others nationwide, have taken a hit during the coronavirus pandemic. The company recently announced plans to close roughly 800 U.S. stores this year, or about 8% of its U.S. locations, as a result.

MORE Health ARTICLES

Health care workers at risk of PTSD from COVID: guide

Health care workers at risk of PTSD from COVID: guide
The Centre of Excellence on Post-Traumatic Stress Disorder says health-care workers on the front lines of the COVID-19 pandemic are susceptible to severe stress that could cause long-term psychological damage.

Health care workers at risk of PTSD from COVID: guide

Doctors say experimental treatment may have rid man of HIV

Doctors say experimental treatment may have rid man of HIV
A Brazilian man infected with the AIDS virus has shown no sign of it for more than a year since he stopped HIV medicines after an intense experimental drug therapy aimed at purging hidden, dormant virus from his body, doctors reported Tuesday.

Doctors say experimental treatment may have rid man of HIV

AIDS report: Kids are lagging and COVID-19 is harming care

AIDS report: Kids are lagging and COVID-19 is harming care
New numbers on the global AIDS epidemic show some big successes, such as fewer deaths and new infections. But there are also some tragic failures: Only half the children with HIV, the virus that causes the disease, are getting treatment.

AIDS report: Kids are lagging and COVID-19 is harming care

Dr.Bal Pawa shares information on how to tackle mental health challenges amidst COVID-19

Dr.Bal Pawa shares information on how to tackle mental health challenges amidst COVID-19
Dr. Bal Pawa is a uniquely qualified pharmacist and medical doctor. The combined knowledge, plus 3 decades of clinical experience have fuelled her passion to change the way medical care is delivered

Dr.Bal Pawa shares information on how to tackle mental health challenges amidst COVID-19

Gilead's $2,340 price for coronavirus drug draws criticism

Gilead's $2,340 price for coronavirus drug draws criticism
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.

Gilead's $2,340 price for coronavirus drug draws criticism

Serious coronavirus-linked condition hit 285 US children

Serious coronavirus-linked condition hit 285 US children
At least 285 U.S. children have developed a serious inflammatory condition linked to the coronavirus and while most recovered, the potential for long-term or permanent damage is unknown, two new studies suggest.

Serious coronavirus-linked condition hit 285 US children